DK386086D0 - Substituerede 1,4-dihydro-pyridinderivater samt deres fremstilling og anvendelse - Google Patents

Substituerede 1,4-dihydro-pyridinderivater samt deres fremstilling og anvendelse

Info

Publication number
DK386086D0
DK386086D0 DK386086A DK386086A DK386086D0 DK 386086 D0 DK386086 D0 DK 386086D0 DK 386086 A DK386086 A DK 386086A DK 386086 A DK386086 A DK 386086A DK 386086 D0 DK386086 D0 DK 386086D0
Authority
DK
Denmark
Prior art keywords
dihydro
substituted
preparation
pyridine derivatives
pyridine
Prior art date
Application number
DK386086A
Other languages
English (en)
Other versions
DK386086A (da
Inventor
Kurt Eichenberger
Hans Kuehnis
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK386086D0 publication Critical patent/DK386086D0/da
Publication of DK386086A publication Critical patent/DK386086A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Liquid Crystal Substances (AREA)
  • Paper (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Hydrogenated Pyridines (AREA)
DK386086A 1985-08-14 1986-08-13 Substituerede 1,4-dihydro-pyridinderivater samt deres fremstilling og anvendelse DK386086A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH350485 1985-08-14

Publications (2)

Publication Number Publication Date
DK386086D0 true DK386086D0 (da) 1986-08-13
DK386086A DK386086A (da) 1987-02-15

Family

ID=4257414

Family Applications (1)

Application Number Title Priority Date Filing Date
DK386086A DK386086A (da) 1985-08-14 1986-08-13 Substituerede 1,4-dihydro-pyridinderivater samt deres fremstilling og anvendelse

Country Status (14)

Country Link
US (1) US4808603A (da)
EP (1) EP0214094A1 (da)
JP (1) JPS6239569A (da)
KR (1) KR870002077A (da)
AU (1) AU6110386A (da)
DD (1) DD258604A5 (da)
DK (1) DK386086A (da)
ES (1) ES2000865A6 (da)
FI (1) FI863238A (da)
GR (1) GR862105B (da)
HU (1) HU196961B (da)
NO (1) NO863269L (da)
PT (1) PT83192B (da)
ZA (1) ZA866082B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63135381A (ja) * 1986-11-26 1988-06-07 Kyorin Pharmaceut Co Ltd 多剤耐性癌細胞に対する感受性増強剤及びその製造方法
JP2861274B2 (ja) * 1989-06-06 1999-02-24 武田薬品工業株式会社 アミノケトン誘導体
US5434179A (en) * 1989-06-06 1995-07-18 Takeda Chemical Industries, Ltd. Method for improving brain function using cholinesterase-inhibiting aminoketone compounds
FR2671349B1 (fr) * 1991-01-09 1993-04-23 Lafon Labor Nouveaux derives de 1,4-dihydropyridine, leur procede de preparation et composition therapeutique les contenant.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0145956A1 (de) * 1983-11-16 1985-06-26 Ciba-Geigy Ag Neue Amid-Verbindungen
JPS60156671A (ja) * 1984-01-25 1985-08-16 Yamanouchi Pharmaceut Co Ltd ジヒドロピリジン誘導体およびその製造法

Also Published As

Publication number Publication date
FI863238A0 (fi) 1986-08-08
GR862105B (en) 1986-12-30
HUT41733A (en) 1987-05-28
NO863269L (no) 1987-02-16
NO863269D0 (no) 1986-08-13
DD258604A5 (de) 1988-07-27
FI863238A (fi) 1987-02-15
HU196961B (en) 1989-02-28
JPS6239569A (ja) 1987-02-20
PT83192A (en) 1986-09-01
DK386086A (da) 1987-02-15
ES2000865A6 (es) 1988-03-16
US4808603A (en) 1989-02-28
PT83192B (en) 1988-09-22
AU6110386A (en) 1987-02-19
ZA866082B (en) 1987-03-25
KR870002077A (ko) 1987-03-30
EP0214094A1 (de) 1987-03-11

Similar Documents

Publication Publication Date Title
DK289886A (da) Substituerede 3-phenyl-4-cyanopyrrol-derivater samt deres fremstilling og anvendelse
DK559985A (da) 13beta-milbemycinderivater samt deres fremstilling og anvendelse
DK416985D0 (da) Substitueret 1,4-dihydropyridincarbonyl-piperidinoforbindelser samt deres fremstilling og anvendelse
DK29686D0 (da) 13beta-alkyl-milbemycinderivater samt deres fremstilling og anvendelse
DK578185A (da) 13beta-milbemycinderivater samt deres fremstilling og anvendelse
DK618886D0 (da) 6,7,8,9-tetrahydro-10-methylpyrido-(1,2-a)-indol-9-aminer og derivater deraf, samt deres fremstilling og anvendelse
DK81586D0 (da) Tricycliske 1,2-dihydronaphthalenderivater samt deres fremstilling og anvendelse
DK537785D0 (da) Flavolignanderivater samt deres fremstilling og anvendelse
DK393485A (da) 1,4-dihydropyridiner, deres fremstilling og anvendelse
DK77186D0 (da) 1,4,6-tri-0-acylerede hexosederivater samt deres fremstilling og anvendelse
DK386086D0 (da) Substituerede 1,4-dihydro-pyridinderivater samt deres fremstilling og anvendelse
DK119585D0 (da) 1,2,4-triazacycloalkadienderivater samt deres fremstilling og anvendelse
DK236585A (da) Acylerede hexosederivater samt deres fremstilling og anvendelse
DK548586D0 (da) Thienylsulfonylguanidin-derivater, deres fremstilling og anvendelse
DK527886D0 (da) 2,3,4,6-tetrasubstituerede 1,4-dihydropyridin-5-carboxylsyrederivater samt deres fremstilling og anvendelse
DK406486D0 (da) Hydropyridinderivater samt deres fremstilling og anvendelse
DK8887A (da) Substituerede 1,3,5-oxadiazin-2-oner samt deres fremstilling og anvendelse
DK422685A (da) Benzazolderivater samt deres fremstilling og anvendelse
DK538385D0 (da) 1,4-dihydropyridiner, deres fremstilling og anvendelse
DK77286D0 (da) 1-0-acylerede hexosederivater samt deres fremstilling og anvendelse
DK153285A (da) Benzodioxolderivater samt deres fremstilling og anvendelse
DK119685D0 (da) 3-mercapto-1,2,4-triazacycloalkadienderivater samt deres fremstilling og anvendelse
DK447687A (da) Urdamycin g og derivater deraf samt deres fremstilling og anvendelse
DK117587A (da) 5-acyloxy-13beta-alkyl-milbemycin-derivater samt deres fremstilling og anvendelse
DK133687D0 (da) Pyridinderivater samt deres fremstilling og anvendelse

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment